Join us for a new virtual series hosted by DPA!
Dear Friend,
With nearly 100,000 overdose deaths each year, we are all concerned for our loved ones and communities. In order to save lives, we have to understand a root cause of this crisis: an unpredictable drug supply.
Join us on Thursday, March 13th as we kick off the four-part virtual series: New Drugs and Markets: Meeting the Challenge of a Changing Drug Policy Landscape.
==
[link removed]
==
This series will explore the new and emerging synthetic drugs in the United States and solutions to reduce overdose and other drug-related health risks. Panelists will also discuss the harms faced by people who use drugs and important changes to drug markets.
Learn more and register for each session:
Keynote and Panel 1: Understanding the Current Drug Supply (Thursday, March 13, 3:00 pm ET)
==
[link removed]
==
Panel 2: Addressing Myths, Misinformation, and Real Harms (Thursday, April 10, 3:30 pm ET)
==
[link removed]
==
Panel 3: Understanding Drug Markets (Thursday, May 8, 3:30 pm ET)
==
[link removed]
==
Panel 4: Scaling Up Drug Checking, Envisioning Safe Supply, and Exploring New Horizons (Thursday, May 29, 3:00 pm ET)
==
[link removed]
==
Even as current drug policies create new and likely more dangerous drugs, we must envision solutions that are just as innovative as these new markets.
Tune in to learn from leading experts on understanding the drug supply, combating misinformation, and saving lives.
==
[link removed]
==
We hope to see you there!
Thank you,
Jules Netherland, PhD
Managing Director of Research and Academic Engagement
Donate to DPA: [link removed]
Website: [link removed]
X/Twitter: [link removed]
Facebook: [link removed]
Linkedin: [link removed]
Instagram: [link removed]
Youtube: [link removed]
TikTok: [link removed]
You have received this email because
[email protected] is a member of the Drug Policy Alliance mailing list.
Copyright © 2025 Drug Policy Alliance. All Rights Reserved.
131 West 33rd St., 15th Floor, New York, NY 10001
Terms and Conditions
[link removed]
Privacy Policy
[link removed]
Email Preferences
[link removed]
